Ukraine’s Health System Braces for Toughest Winter as Russia Targets Critical Infrastructure 13/09/2024 Stefan Anderson As Russian missiles rain down on hospitals and critical energy infrastructure keeping their lights on, Ukraine’s health system faces what could be its most challenging season yet in its third winter of full-scale war, the World Health Organization’s top European official warned Thursday. “This will likely be the toughest winter of the three that Ukraine […] Continue reading -> DR Congo to Launch Mpox Vaccine Drive in Early October; UNHCR seeks over $21 Million to Support Refugees in Outbreak Hotspots 12/09/2024 Paul Adepoju The Democratic Republic of Congo (DRC) is planning to launch its mpox vaccination campaign in early October, marking a critical step in the fight against the ongoing outbreak across Africa, said Dr Jean Kaseya, Director-General of the African Centres for Disease Control and Protection (Africa CDC), on Thursday. Kaseya spoke at a press briefing following […] Continue reading -> Mpox Injects Urgency into Resumed Talks on Pandemic Agreement 09/09/2024 Kerry Cullinan The mpox outbreak – characterised by the all-too-familiar lack of vaccines for Africa – provided added impetus to the global negotiations for a pandemic agreement, which resumed at the World Health Organization (WHO) headquarters in Geneva on Monday. Ethiopia, speaking for Africa, said that mpox, recently declared a public health emergency of international concern, “calls […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Warming Oceans Fuel Tropical Storms in Asia – and Threaten Pacific Islands 29/08/2024 Kerry Cullinan Japan issued a rare Level 4 evacuation advisory for its southern island, Kyushu, affecting 3.7 million residents as Typhoon Shanshan made landfall on Thursday. The storm is the strongest to hit the country this year, and has caused widespread power cuts as well as floods. Level 4 is the country’s second-highest alert level. In Bangladesh, […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
DR Congo to Launch Mpox Vaccine Drive in Early October; UNHCR seeks over $21 Million to Support Refugees in Outbreak Hotspots 12/09/2024 Paul Adepoju The Democratic Republic of Congo (DRC) is planning to launch its mpox vaccination campaign in early October, marking a critical step in the fight against the ongoing outbreak across Africa, said Dr Jean Kaseya, Director-General of the African Centres for Disease Control and Protection (Africa CDC), on Thursday. Kaseya spoke at a press briefing following […] Continue reading -> Mpox Injects Urgency into Resumed Talks on Pandemic Agreement 09/09/2024 Kerry Cullinan The mpox outbreak – characterised by the all-too-familiar lack of vaccines for Africa – provided added impetus to the global negotiations for a pandemic agreement, which resumed at the World Health Organization (WHO) headquarters in Geneva on Monday. Ethiopia, speaking for Africa, said that mpox, recently declared a public health emergency of international concern, “calls […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Warming Oceans Fuel Tropical Storms in Asia – and Threaten Pacific Islands 29/08/2024 Kerry Cullinan Japan issued a rare Level 4 evacuation advisory for its southern island, Kyushu, affecting 3.7 million residents as Typhoon Shanshan made landfall on Thursday. The storm is the strongest to hit the country this year, and has caused widespread power cuts as well as floods. Level 4 is the country’s second-highest alert level. In Bangladesh, […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mpox Injects Urgency into Resumed Talks on Pandemic Agreement 09/09/2024 Kerry Cullinan The mpox outbreak – characterised by the all-too-familiar lack of vaccines for Africa – provided added impetus to the global negotiations for a pandemic agreement, which resumed at the World Health Organization (WHO) headquarters in Geneva on Monday. Ethiopia, speaking for Africa, said that mpox, recently declared a public health emergency of international concern, “calls […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Warming Oceans Fuel Tropical Storms in Asia – and Threaten Pacific Islands 29/08/2024 Kerry Cullinan Japan issued a rare Level 4 evacuation advisory for its southern island, Kyushu, affecting 3.7 million residents as Typhoon Shanshan made landfall on Thursday. The storm is the strongest to hit the country this year, and has caused widespread power cuts as well as floods. Level 4 is the country’s second-highest alert level. In Bangladesh, […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Warming Oceans Fuel Tropical Storms in Asia – and Threaten Pacific Islands 29/08/2024 Kerry Cullinan Japan issued a rare Level 4 evacuation advisory for its southern island, Kyushu, affecting 3.7 million residents as Typhoon Shanshan made landfall on Thursday. The storm is the strongest to hit the country this year, and has caused widespread power cuts as well as floods. Level 4 is the country’s second-highest alert level. In Bangladesh, […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Warming Oceans Fuel Tropical Storms in Asia – and Threaten Pacific Islands 29/08/2024 Kerry Cullinan Japan issued a rare Level 4 evacuation advisory for its southern island, Kyushu, affecting 3.7 million residents as Typhoon Shanshan made landfall on Thursday. The storm is the strongest to hit the country this year, and has caused widespread power cuts as well as floods. Level 4 is the country’s second-highest alert level. In Bangladesh, […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa CDC in Talks with Bavarian Nordic to Bring Mpox Vaccine Production to the Continent 20/08/2024 Kerry Cullinan The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about technology transfer to enable African manufacturers to make the vaccine on the continent. “I want to recognise and thank Bavarian Nordic for accepting to do the tech transfer in Africa, […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa CDC to Declare First-Ever Continental Health Emergency as Mpox Surges 08/08/2024 Paul Adepoju & Stefan Anderson The Africa Centres for Disease Control and Prevention (Africa CDC) plans to declare mpox a public health emergency of continental concern next week, marking the first such declaration in the agency’s history. The decision follows a surge in mpox cases across Africa in 2024, matching 2023’s total in just six months. Since January 2022, over […] Continue reading -> Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Hans Kluge: WHO Europe’s Quest for Cheaper Medicine 31/07/2024 Kerry Cullinan The World Health Organization’s (WHO) vast European region – 53 countries, including the entire European Union, Russia and even Israel – is often excluded from cheaper medicine deals because of member states’ high- and middle-income status. But one of the flagship programmes of WHO regional director Dr Hans Kluge is the Novel Medicines Platform (NMP), […] Continue reading -> Posts navigation Older postsNewer posts